Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 24, 2026 23:37 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 156 | $7.06 | $1,101.16 |
DisclosureSEC source: 0001493152-26-044207 · ownership.xml · nonDerivative · entry 3 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 589,518 Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 23:37 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 27 | $6.95 | $187.65 |
DisclosureSEC source: 0001493152-26-044207 · ownership.xml · nonDerivative · entry 2 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 589,674 Read SEC document |
| September 22, 2026 Filed Sep 24, 2026 23:37 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 723 | $0.55 | $397.65 |
DisclosureSEC source: 0001493152-26-044207 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 589,701 Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 21:06 UTC |
Macko Todd DChief Financial Officer
|
SaleCommon Stock | 43,400 | $0.56 | $24,369.10 |
DisclosureSEC source: 0001493152-26-013708 · ownership.xml · nonDerivative · entry 2 Macko Todd D · CIK 0001830744 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,122 Read SEC document |
| March 25, 2026 Filed Mar 30, 2026 21:06 UTC |
Macko Todd DChief Financial Officer
|
SaleCommon Stock | 1,600 | $0.60 | $961.28 |
DisclosureSEC source: 0001493152-26-013708 · ownership.xml · nonDerivative · entry 1 Macko Todd D · CIK 0001830744 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,122 Read SEC document |
| March 23, 2026 Filed Mar 25, 2026 19:55 UTC |
Grady JasonDirector
|
SaleCommon Stock | 50,000 | $0.65 | $32,505.00 |
DisclosureSEC source: 0001493152-26-012746 · ownership.xml · nonDerivative · entry 1 Grady Jason · CIK 0001782482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,182 Read SEC document |
| May 27, 2025 Filed May 27, 2025 20:35 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 45,400 | $0.54 | $24,529.62 |
DisclosureSEC source: 0001641172-25-012502 · ownership.xml · nonDerivative · entry 3 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 27, 2025 Filed Jan 6, 2026 22:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 45,400 | $0.54 | $24,529.62 |
DisclosureSEC source: 0001493152-26-000635 · ownership.xml · nonDerivative · entry 2 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 545,024 Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:35 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 115,600 | $0.55 | $63,475.96 |
DisclosureSEC source: 0001641172-25-012502 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,400 Read SEC document |
| May 22, 2025 Filed Jan 6, 2026 22:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 115,600 | $0.55 | $63,475.96 |
DisclosureSEC source: 0001493152-26-000635 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590,424 Read SEC document |
| April 04, 2025 Filed Apr 4, 2025 21:15 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 180,000 | $0.96 | $172,800.00 |
DisclosureSEC source: 0001641172-25-002819 · ownership.xml · nonDerivative · entry 7 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F7 · price: On April 4, 2025, Global Biomedical Pte. Ltd. sold 180,000 shares of the Issuer's common stock at a weighted average sale price of $0.96 This transaction was executed in multiple trades at prices ranging from $0.93 to $0.997. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. F8 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 01:59 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 890,800 | $0.95 | $845,012.88 |
DisclosureSEC source: 0001641172-25-003114 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,100 Read SEC document |
| April 03, 2025 Filed Apr 4, 2025 21:15 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 273,286 | $0.78 | $212,889.79 |
DisclosureSEC source: 0001641172-25-002819 · ownership.xml · nonDerivative · entry 6 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 180,000 F6 · price: On April 3, 2025, Global Biomedical Pte. Ltd. sold 273,286 shares of the Issuer's common stock at a weighted average sale price of $0.779. This transaction was executed in multiple trades at prices ranging from $0.75 to $0.84. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. F8 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. Read SEC document |
| April 03, 2025 Filed Apr 4, 2025 21:15 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 351,631 | $0.58 | $203,594.35 |
DisclosureSEC source: 0001641172-25-002819 · ownership.xml · nonDerivative · entry 5 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F5 · price: On April 3, 2025, Alset Inc. sold 351,631 shares of the Issuer's common stock at a weighted average sale price of $0.579. This transaction was executed in multiple trades at prices ranging from $0.50 to $0.73. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. F8 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. Read SEC document |
| April 03, 2025 Filed Apr 7, 2025 21:18 UTC |
Chan Heng Fai AmbroseDirector
|
SaleCommon stock | 351,555 | $0.50 | $174,019.73 |
DisclosureSEC source: 0001641172-25-003021 · ownership.xml · nonDerivative · entry 1 Chan Heng Fai Ambrose · CIK 0001261725 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: On April 3, 2025, Alset International Limited sold 351,555 shares of the Issuer's common stock at a weighted average sale price of $0.495. This transaction was executed in multiple trades at prices ranging from $0.46 to $0.57. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. F2 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:15 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 382,427 | $0.58 | $222,954.94 |
DisclosureSEC source: 0001641172-25-002819 · ownership.xml · nonDerivative · entry 4 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 351,631 F4 · price: On April 2, 2025, Alset Inc. sold 382,427 shares of the Issuer's common stock at a weighted average sale price of $0.583. This transaction was executed in multiple trades at prices ranging from $0.57 to $0.63. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. F8 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:15 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 2,349 | $0.67 | $1,580.88 |
DisclosureSEC source: 0001641172-25-002819 · ownership.xml · nonDerivative · entry 3 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 351,555 F3 · price: On April 2, 2025, Alset International Limited sold 2,349 shares of the Issuer's common stock at a weighted average sale price of $0.673. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. F8 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:15 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 200,000 | $0.67 | $134,800.00 |
DisclosureSEC source: 0001641172-25-002819 · ownership.xml · nonDerivative · entry 2 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 353,904 F2 · price: On April 2, 2025, Alset International Limited sold 200,000 shares of the Issuer's common stock at a weighted average sale price of $0.674. This transaction was executed in multiple trades at prices ranging from $0.67 to $0.80. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. F8 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:15 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 300,000 | $0.58 | $174,300.00 |
DisclosureSEC source: 0001641172-25-002819 · ownership.xml · nonDerivative · entry 1 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 553,904 F1 · price: On April 2, 2025, Alset International Limited sold 300,000 shares of the Issuer's common stock at a weighted average sale price of $0.581. This transaction was executed in multiple trades at prices ranging from $0.551 to $0.607. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F8 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. F8 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 01:01 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon Stock | 1,176,918 | $1.08 | $1,271,071.44 |
DisclosureSEC source: 0001641172-25-002479 · ownership.xml · nonDerivative · entry 4 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 734,058 F4 · price: On April 1, 2025, Alset Inc. sold 1,176,918 shares of the Issuer's common stock at a weighted average sale price of $1.08. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F5 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. F5 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 01:01 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon Stock | 650,000 | $1.45 | $940,550.00 |
DisclosureSEC source: 0001641172-25-002479 · ownership.xml · nonDerivative · entry 3 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,910,976 F3 · price: On April 1, 2025, Alset Inc. sold 650,000 shares of the Issuer's common stock at a weighted average sale price of $1.447. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F5 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. F5 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 01:01 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon stock | 400,000 | $0.98 | $392,800.00 |
DisclosureSEC source: 0001641172-25-002479 · ownership.xml · nonDerivative · entry 2 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 853,904 F2 · price: On April 1, 2025, Alset International Limited sold 400,000 shares of the Issuer's common stock at a weighted average sale price of $0.9816. This transaction was executed in multiple trades at prices ranging from $0.6938 to $1.36. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F5 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. F5 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. Read SEC document |
| March 31, 2025 Filed Apr 3, 2025 01:01 UTC |
Chan Heng Fai AmbroseDirector · 10% owner
Alset International Ltd10% owner
Alset Inc.10% owner
|
SaleCommon Stock | 300,000 | $1.03 | $308,400.00 |
DisclosureSEC source: 0001641172-25-002479 · ownership.xml · nonDerivative · entry 1 Chan Heng Fai Ambrose · CIK 0001261725 · Director · 10% owner Alset International Ltd · CIK 0001660984 · 10% owner Alset Inc. · CIK 0001750106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,253,904 F1 · price: On March 31, 2025, Alset International Limited sold 300,000 shares of the Issuer's common stock at a weighted average sale price of $1.028. This transaction was executed in multiple trades at prices ranging from $0.82 to $1.29. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F5 · balance_after: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. F5 · ownership.nature: Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of an aggregate of 2,041,248 shares of common stock through the following entities: (a) 453,286 shares of common stock held by Global Biomedical Pte. Ltd. (a subsidiary of Alset International Limited); (b) 853,904 shares of common stock held by Alset International Limited; and (c) 734,058 shares of common stock held by Alset Inc. Read SEC document |
| March 27, 2025 Filed Mar 28, 2025 21:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 47,681 | $2.50 | $119,254.95 |
DisclosureSEC source: 0001641172-25-001312 · ownership.xml · nonDerivative · entry 6 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,051,800 Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 21:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 9,858 | $3.15 | $31,052.70 |
DisclosureSEC source: 0001641172-25-001312 · ownership.xml · nonDerivative · entry 5 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,099,481 Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 21:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 48,281 | $3.13 | $151,080.91 |
DisclosureSEC source: 0001641172-25-001312 · ownership.xml · nonDerivative · entry 4 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,109,339 Read SEC document |
| March 21, 2025 Filed Mar 28, 2025 21:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 166,600 | $3.30 | $549,846.64 |
DisclosureSEC source: 0001641172-25-001312 · ownership.xml · nonDerivative · entry 3 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By DSS BioHealth Security, Inc. Disclosed balance after: 1,178,882 F1 · ownership.nature: This entity is a wholly-owned subsidiary of DSS, Inc. Read SEC document |
| March 21, 2025 Filed Mar 28, 2025 21:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 166,600 | $3.30 | $549,846.64 |
DisclosureSEC source: 0001641172-25-001312 · ownership.xml · nonDerivative · entry 2 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By DSS BlockChain Security, Inc. Disclosed balance after: 0 F1 · ownership.nature: This entity is a wholly-owned subsidiary of DSS, Inc. Read SEC document |
| March 21, 2025 Filed Mar 28, 2025 21:25 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 166,600 | $3.30 | $549,846.64 |
DisclosureSEC source: 0001641172-25-001312 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By DSS Securities, Inc. Disclosed balance after: 0 F1 · ownership.nature: This entity is a wholly-owned subsidiary of DSS, Inc. Read SEC document |
| March 20, 2025 Filed Mar 25, 2025 00:00 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 53,280 | $4.68 | $249,350.40 |
DisclosureSEC source: 0001641172-25-000403 · ownership.xml · nonDerivative · entry 3 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 0 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| March 20, 2025 Filed Mar 25, 2025 00:00 UTC |
DSS, INC.10% owner
|
PurchaseCommon Stock | 200 | $1.55 | $310.00 |
DisclosureSEC source: 0001641172-25-000403 · ownership.xml · nonDerivative · entry 2 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 53,280 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 16:05 UTC |
Heuszel Frank DDirector · Chief Executive Officer
|
PurchaseCommon Stock | 500 | $2.26 | $1,128.90 |
DisclosureSEC source: 0001493152-24-049260 · ownership.xml · nonDerivative · entry 1 Heuszel Frank D · CIK 0001748704 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,344 Read SEC document |
| December 02, 2024 Filed Mar 25, 2025 00:00 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 20 | $2.90 | $58.00 |
DisclosureSEC source: 0001641172-25-000403 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 53,080 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| November 27, 2024 Filed Dec 3, 2024 21:51 UTC |
Heuszel Frank DDirector · Chief Executive Officer
|
PurchaseCommon Stock | 500 | $2.61 | $1,305.00 |
DisclosureSEC source: 0001493152-24-048579 · ownership.xml · nonDerivative · entry 1 Heuszel Frank D · CIK 0001748704 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,844 Read SEC document |
| November 26, 2024 Filed Dec 3, 2024 21:49 UTC |
Heuszel Frank DDirector · Chief Executive Officer
|
PurchaseCommon Stock | 500 | $2.59 | $1,295.00 |
DisclosureSEC source: 0001493152-24-048576 · ownership.xml · nonDerivative · entry 2 Heuszel Frank D · CIK 0001748704 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,344 Read SEC document |
| November 26, 2024 Filed Dec 3, 2024 21:49 UTC |
Heuszel Frank DDirector · Chief Executive Officer
|
PurchaseCommon Stock | 550 | $2.63 | $1,443.75 |
DisclosureSEC source: 0001493152-24-048576 · ownership.xml · nonDerivative · entry 1 Heuszel Frank D · CIK 0001748704 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,844 Read SEC document |
| November 18, 2024 Filed Nov 22, 2024 21:33 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 5,000 | $3.02 | $15,085.00 |
DisclosureSEC source: 0001493152-24-047410 · ownership.xml · nonDerivative · entry 3 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 53,100 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| November 13, 2024 Filed Nov 22, 2024 21:33 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 200 | $2.80 | $560.00 |
DisclosureSEC source: 0001493152-24-047410 · ownership.xml · nonDerivative · entry 2 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 58,100 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| November 12, 2024 Filed Nov 22, 2024 21:33 UTC |
DSS, INC.10% owner
|
SaleCommon Stock | 500 | $2.76 | $1,378.50 |
DisclosureSEC source: 0001493152-24-047410 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 58,300 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| September 18, 2024 Filed Sep 19, 2024 23:07 UTC |
DSS, INC.10% owner
|
PurchaseCommon Stock | 1,000 | $2.33 | $2,330.00 |
DisclosureSEC source: 0001493152-24-037196 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 58,800 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 00:53 UTC |
DSS, INC.10% owner
|
PurchaseCommon Stock | 7,800 | $2.40 | $18,720.00 |
DisclosureSEC source: 0001493152-24-037044 · ownership.xml · nonDerivative · entry 2 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 57,800 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
| September 16, 2024 Filed Sep 19, 2024 00:53 UTC |
DSS, INC.10% owner
|
PurchaseCommon Stock | 50,000 | $2.69 | $134,500.00 |
DisclosureSEC source: 0001493152-24-037044 · ownership.xml · nonDerivative · entry 1 DSS, INC. · CIK 0000771999 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sentinel Brokers Company, Inc. Disclosed balance after: 50,000 F1 · ownership.nature: Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.